Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The impact of prescription drug costs on health spending

Cathleen London, MD
Meds
June 10, 2012
Share
Tweet
Share

I am employed by a hospital, and have health insurance through my job. The coverage is comprehensive, and the cost has an employer contribution and employee contribution. I still get confused (though I have the hospital’s own plan) about what is covered and what is not. I can only imagine how hard it must be for my patients.

The prescription plan that comes with this insurance is straight forward: $40 for brand name pharmaceuticals (for ones on the formulary), and $10-$15 for generics. There are some exceptions to this price structure, but it is fairly simple.

I recently switched pharmacies, and had prescriptions transferred to the new big chain pharmacy. One prescription is for a generic medication, the other prescription is for a brand name (old medication that has been around a long time). The new pharmacy did not yet have my insurance information so I was not surprised that when I received an email that my prescriptions were ready I did not see the copays I listed above. Instead, 30 pills of the generic medication were $68 and the branded $148.

When I went to pick up the medications, my 14 year old son was with me. He wanted to know if it was for some new rarified prescription agent as he was shocked at the cost being so high. I explained that actually those prices are low – new drugs, particularly chemotherapeutic agents could be thousands per month.

I was, however, a bit surprised at the price, so when we got home, I looked it up. The sticker price of the one that this big chain wanted to charge me $148 for 30 pills is $84.97 for 90 pills. The sticker price of the generic medication that they wanted to charge me $68 is $15 for 30 pills.

How can we possibly reign in medical costs when our pharmaceutical costs exceed that of any other nation (the excuse being funding research and development but that does not explain why we pay for the whole world’s drug supply) and further pharmacies are taking advantage of us?

I understand profit but this is seriously out of hand. Year after year drug companies enjoy higher profits than any other industry – on the order of 17% compared with 3.1% of non pharmaceutical companies on the Fortune 500 list. The pharmaceutical industry claims to be a high-risk business however business that is consistently so profitable can hardly be considered risky. This profit comes from excess prices, only paid in the United States.

Right now, prescription drug costs are only 11% of healthcare spending but it is the fastest rising sector. With an aging population that percentage is shifting. Thanks to the obesity epidemic we can expect spending on hypertension, diabetes and other complications are going to go up, with medications the mainstay of therapy. We need accountability – from insurers, pharmaceutical companies and pharmacies.

Cathleen London is a physician who blogs at Progress Notes.

Prev

Is there a harm to not seeing drug reps?

June 10, 2012 Kevin 35
…
Next

Prepare your medical information for evacuation

June 11, 2012 Kevin 3
…

Tagged as: Cardiology, Medications, Public Health & Policy

Post navigation

< Previous Post
Is there a harm to not seeing drug reps?
Next Post >
Prepare your medical information for evacuation

ADVERTISEMENT

More by Cathleen London, MD

  • A physician applies to law school. Here is her application essay.

    Cathleen London, MD
  • Our noble profession is being destroyed by legislators and administrators

    Cathleen London, MD
  • A physician tells a health insurance CEO what she really thinks

    Cathleen London, MD

More in Meds

  • FDA delays could end vital treatment for rare disease patients

    G. van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 6 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The impact of prescription drug costs on health spending
6 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...